Can a second dose of targeted radiation keep prostate cancer in check?
NCT ID NCT06866938
First seen Jan 10, 2026 · Last updated May 24, 2026 · Updated 25 times
Summary
This study looks at whether giving a second course of a targeted radiation drug (Lu-PSMA) can help men with advanced prostate cancer that has stopped responding to hormone therapy. About 58 men who previously benefited from this treatment will receive it again. The goal is to see how long the cancer stays under control and to monitor side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION RESISTANT PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Nancy
NOT_YET_RECRUITINGVandœuvre-lès-Nancy, 54511, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hôpital Louis Pradel, Hospices Civils de Lyon
NOT_YET_RECRUITINGBron, 69500, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Institut de cancérologie du Gard
NOT_YET_RECRUITINGNîmes, 30000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Médecine Nucléaire, CHU de Nantes Hôtel-Dieu
NOT_YET_RECRUITINGNantes, 44000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Médecine Nucléaire, Centre Hospitalier de Grenoble Alpes
NOT_YET_RECRUITINGGrenoble, 38043, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Médecine Nucléaire, Centre Léon Berard
NOT_YET_RECRUITINGLyon, 69373, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Médecine Nucléaire, Institut Bergonié
NOT_YET_RECRUITINGBordeaux, 33000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Médecine Nucléaire, Institut Gustave Roussy
NOT_YET_RECRUITINGVillejuif, 94800, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Médecine Nucléaire, Institut de Cancérologie de Strasbourg
NOT_YET_RECRUITINGStrasbourg, 67200, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Oncologie Médicale, CHU Brest-Hôpital Morvan
NOT_YET_RECRUITINGBrest, 29200, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Oncologie Médicale, CHU Saint Etienne
NOT_YET_RECRUITINGSaint-Priest-en-Jarez, 42270, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Oncologie Médicale, Centre Antoine Lacassagne
NOT_YET_RECRUITINGNice, 06189, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Oncologie Médicale, Centre François Baclesse
NOT_YET_RECRUITINGCaen, 14076, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Oncologie Médicale, Centre Henri Becqueret
NOT_YET_RECRUITINGRouen, 76038, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Oncologie Médicale, Centre Hospitalier Lyon Sud, HCL
RECRUITINGPierre-Bénite, 69310, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Oncologie Médicale, Centre Jean Perrin
NOT_YET_RECRUITINGClermont-Ferrand, 63011, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.